Nventa Biopharmaceuticals Overview

  • Founded
  • 1990
  • Status
  • Acquired/​Merged
  • Employees
  • 2
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

Nventa Biopharmaceuticals General Information


Developer of therapeutics and drug delivery technologies. The company engages in the development of therapeutics for the treatment of viral infections and cancers, with a focus on diseases caused by the human papillomavirus.

Contact Information

Formerly Known As
StressGen Biotechnologies
Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Akela Pharma
Primary Office
  • 9381 Judicial Drive
  • Suite 180
  • San Diego, CA 92121
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nventa Biopharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nventa Biopharmaceuticals‘s full profile, request access.

Request a free trial

Nventa Biopharmaceuticals Patents

Nventa Biopharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20110038888-A1 Adjuvant compositions comprising poly-ic and a cationic polymer Abandoned 10-Jan-2008 00000000000 0
EP-2247308-A4 Adjuvant compositions comprising poly-ic and a cationic polymer Withdrawn 10-Jan-2008 00000000000
EP-2247308-A1 Adjuvant compositions comprising poly-ic and a cationic polymer Withdrawn 10-Jan-2008 00000000000
US-20030050469-A1 Detection of modulators of immune response; obtain cell sample, incubate with fusion proteins, monitor cells for immune response Granted 08-Jul-1999 000000000
US-20050089841-A1 Generating immune response utilizing tumor antigen and/or pathogen antigen fusions; immunotherapy; tissue targeted therapy Abandoned 08-Jul-1999 C07K14/35 00

Nventa Biopharmaceuticals Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial